UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2021-08, Vol.144 (9), p.e171-e191

2021

Volltextzugriff (PDF)

Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation

Journal of the American College of Cardiology, 2015-08, Vol.66 (6), p.616-627

2015

Volltextzugriff (PDF)

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502

2016

Volltextzugriff (PDF)

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions

Journal of cardiovascular development and disease, 2023-04, Vol.10 (4), p.164

2023

Volltextzugriff (PDF)

Sex Differences in Peripheral Artery Disease

Circulation research, 2022-02, Vol.130 (4), p.496-511

2022

Volltextzugriff (PDF)

Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease

Circulation. Cardiovascular interventions, 2020-10, Vol.13 (10), p.e009584-e009584

2020

Volltextzugriff (PDF)

Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV

Circulation (New York, N.Y.), 2014-10, Vol.130 (17), p.1445-1451

2014

Volltextzugriff (PDF)

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2534-2555

2017

Volltextzugriff (PDF)

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Circulation (New York, N.Y.), 2019-08, Vol.140 (7), p.556-565

2019

Volltextzugriff (PDF)

The Learning Curve for Transradial Percutaneous Coronary Intervention Among Operators in the United States: A Study From the National Cardiovascular Data Registry

Circulation (New York, N.Y.), 2014-06, Vol.129 (22), p.2277-2286

2014

Volltextzugriff (PDF)

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Circulation (New York, N.Y.), 2020-12, Vol.142 (23), p.2219-2230

2020

Volltextzugriff (PDF)

Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention

Circulation. Cardiovascular interventions, 2022-08, Vol.15 (8), p.e011768

2022

Volltextzugriff (PDF)

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2023-12, Vol.148 (24), p.1919

2023

Volltextzugriff (PDF)

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (14), p.1104-1116

2021

Volltextzugriff (PDF)

Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2024-05, Vol.149 (19), p.1536

2024

Volltextzugriff (PDF)

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2021-12, Vol.144 (23), p.1831-1841

2021

Volltextzugriff (PDF)

Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative"

Circulation (New York, N.Y.), 2017-12, Vol.136 (25), p.2524-2525

2017

Volltextzugriff (PDF)

Race and Sex Differences in Post-Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization

Circulation (New York, N.Y.), 2017-02, Vol.135 (6), p.532-543

2017

Volltextzugriff (PDF)

2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures

Circulation Cardiovascular quality and outcomes, 2023-09, Vol.16 (9), p.e000121-e00121

2023

Volltextzugriff (PDF)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

Journal of thrombosis and haemostasis, 2022-05, Vol.20 (5), p.1193-1205

2022

Volltextzugriff (PDF)

Association of Early Physician Follow-Up and 30-Day Readmission After Non–ST-Segment–Elevation Myocardial Infarction Among Older Patients

Circulation (New York, N.Y.), 2013-09, Vol.128 (11), p.1206-1213

2013

Volltextzugriff (PDF)

Treatment of coronary artery disease in cancer survivors: an emerging challenge

Coronary artery disease, 2017-01, Vol.28 (1), p.1-2

2017

Volltextzugriff (PDF)

Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study

Circulation (New York, N.Y.), 2016-02, Vol.133 (5), p.493-501

2016

Volltextzugriff (PDF)

Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial

Circulation. Cardiovascular interventions, 2021-07, Vol.14 (7), p.e009871-e009871

2021

Volltextzugriff (PDF)

Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women

Circulation. Cardiovascular interventions, 2019-05, Vol.12 (5), p.e007086-e007086

2019

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Cardiovascular System & Cardiology
(28)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Cardiac & Cardiovascular Systems
(27)
Humans
(22)
Peripheral Vascular Disease
(18)
Female
(17)
Male
(16)
Aged
(12)
Middle Aged
(11)
Treatment Outcome
(9)
Peripheral Artery Disease
(7)
Rivaroxaban
(7)
Peripheral Arterial Disease - Drug Therapy
(6)
Lower Extremity - Blood Supply
(5)
Myocardial Infarction - Therapy
(5)
Percutaneous Coronary Intervention
(5)
Peripheral Arterial Disease
(5)
Registries
(5)
Risk Factors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions

Sex Differences in Peripheral Artery Disease

Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease

Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

The Learning Curve for Transradial Percutaneous Coronary Intervention Among Operators in the United States: A Study From the National Cardiovascular Data Registry

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative"

Race and Sex Differences in Post-Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization

2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

Association of Early Physician Follow-Up and 30-Day Readmission After Non–ST-Segment–Elevation Myocardial Infarction Among Older Patients

Treatment of coronary artery disease in cancer survivors: an emerging challenge

Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study

Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial

Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women

Aktive Filter

Suchergebnisse filtern